ERIS logo

ERIS Lifesciences Limited

ERIS·NSE·
1,273.60 -26.30 (-2.02%)
Market Cap17756.68 Cr
PE Ratio28.48
Volume22,902
Day High - Low1295.90 - 1265.10
52W High-Low1799.00 - 1200.00
DocStoX Score
5.3/10
Weak
Fair Value
Sign in to see
ROE
18.70%
Strong
P/E
28.48x
Fair
Debt / Equity
0.66
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250
Day1265
1296
52W1200
1799
DocStoX take

Supported by risk (7.7) and quality (7.5), but held back by momentum (0.0). Risk looks strong at 7.7, but that is offset by momentum at 0.0 and valuation at 2.5. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.3
/10
Weak
Quality
Excellent
ROE 18.7%
Valuation
Expensive
P/E 28.5×
Growth
Steady
Revenue +20.9% 5Y CAGR
Risk
Low risk
D/E 0.66
Momentum
Weak
12% of 52-week range

At a glance

Market Cap
₹17,757 Cr
52W High / Low
₹1799 / ₹1200
Dividend Yield
0.55%
Promoter Holding
54.14%
EPS (TTM)
₹44.72
Book Value
₹282.00

Key highlights

  • Profitable in all of the last 5 years
  • Revenue compounding 21% a year
  • Healthy net margin (21%)
  • Momentum is weak (0.0/10)
  • Near the bottom of its 52-week range (12%)
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

ERIS LIFESCIENCES LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.